Abstract
The study was carried out to find out predictors of axillary lymph node metastasis in breast cancer and to evaluate its significance in selecting the group of patients in whom axillary dissection could be avoided. Ninety-five breast cancer patients who underwent mastectomy and axillary dissection were included in the study. Factors like patient’s age, tumor size, histopathological type, histological grade and estrogen and progesterone receptor status were correlated with the axillary metastases. Out of 95 cases axillary metastasis was found in 47 (49.47%) cases. There was no correlation between patient’s age and tumor size with axillary metastasis (p > 0.05). Based on histopathological typing tumors like ductal carcinoma in situ, tubular carcinoma and mucinous carcinoma showed less tendency for axillary metastasis (p < 0.046). Association was found between histological grade and estrogen receptor and progesterone receptor positivity with presence of axillary metastasis (p < 0.001 and 0.002 respectively). The findings in this study indicate that breast cancer patients having favorable histological type, grade I tumors and estrogen and progesterone receptor negative tumor are good candidates to avoid axillary dissection.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Carter CL, Allen C, Henson DE (1989) Relation of tumors size, lymph node status and survival in 24,740 breast cancer cases. Cancer 63:181–187
Jatoi I, Miller AB (2003) Why is breast cancer mortality declining? Lancet Oncol 4:251–254
Tan LGL, Tan YY, Heng D, Chan MY (2005) Predictors of axillary lymph nodemetastases in women with early breast cancer in Singapore. Singapore Med J 46(12):693–697
Haffty BG, Ward B, Pathare P, Salem R, McKhann C, Beinfield M et al (1997) Reappraisal of the role of axillary lymph node dissection in the conservative treatment of breast cancer. J Clin Oncol 15:691–700
Frierson HF Jr, Wolber RA, Berean KW, Franquemont DW, Gaffey MJ, Boyd JC, Wilbur DC (1995) Interobserver reproducibility of the Nottinghamm modification of the Bloom and Richardson histologic grading scheme for infiltrating ductal carcinoma. Am J Clin Pathol 103:195–198
Murthy NS, Chaudhry K, Nadayil D, Agarwal UK, Saxena S (2009) Changing trends in incidence of breast cancer: Indian scenario. Indian J Cancer 46:73–74
Moore MP, Kinne DW (1997) Axillary lymphadenectomy:a diagnostic and therapeutic procedure. Surg Oncol 66(1):2–6
Alastair M, Thompson (1999) Axillary node clearance for breast cancer. J R Coll Surg Edinb 44:111–117
Jatoi I (1999) Management of the axilla in primary breast cancer. Surg Clin N Am 79:1061–1073
Yip CH, Taib NA, Tan GH, Ng KL, Yoong BK, Choo WY (2009) Predictors of axillary lymph node metastases in breast cancer: is there a role for minimal axillary surgery? Word J Surg 33(1):54–57
Tatjana Ivkoviæ-Kapicl, Milana Panjkoviæ, Dejan Ninèiæ1, Slavica Kne¾eviæ-U¹aj.Factors correlating with lymph node metastases in patients with T1 ductal invasive breast cancer. Arch Oncol 2006;14(1–2):19–22
Iwasaki Y, Fukutomi T, Akashi-Tanaka S, Nanasawa T, Tsuda H (1998) Axillary node metastasis from T1N0M0 breast cancer: possible avoidance of dissection in a subgroup. Jpn J Clin Oncol 28:601–603
Henson DE (1988) Histological grading of breast cancer: Significance of grade on recurrence and mortality. Arch Pathol Lab Med 112:1091–1096
Hapton DS, Thorogood J, Clayden AD (1989) Histological grading of breast cancer: significance of grade on recurrence and mortality. Eur J Surg Oncol 15:25–31
Tot T (2002) Assessment of the most important prognostic factors. In: Tot T, Tabar L, Dean P (eds) Practical breast pathology. Thieme Medical Publishers, New York, pp 125–135
Aye Thike; Mei Jiuan Chng; Stephanie Fook-Chong; Puay Hoon Tan (2001) Immunohistochemical expression of hormone receptors invasive breast carcinoma: correlation of results of H-score with pathological parameters. Pathology 33(1):21–25
Viale G, Zurrida S, Maiorano E et al (2005) Predicting the status of axillary sentinel lymph nodes in 4351 patients with invasive breast carcinoma treated in a single institution. Cancer 103:492–500
Hlgreno J, Tal L, Estman G, Nesson L-G (1994) Prediction of axillary lymph node metastases in screened breast cancer population. Acta Oncol 33(6):603–608
Pavlista D, Dusková M, Novotný J, Zikán M, Strunová M, Freitag P, Zivný J (2002) Complications of axillary dissection in breast carcinoma. Ceská Gynekol 67(6):333–337
Ponzone R, Biglia N, Maggiorotto F, Kubatzki F, Elia O, De Rosa G, Sismondi P (2003) Sentinel node dissection as definitive treatment fornode negative breast cancer patients. EJSO 29:703–706
Jaderborg JM, Harrison PB, Kiser JL (1999) Maynard SL The feasibility and accuracy of the sentinel lymph node biopsy for breast carcinoma. Am Surg 65(8):699–705
Rehman S, Sardi A, Spiegler E, Coandrea J, Frishberg D (1999) Sentinel lymph node mapping for staging breast cancer: preliminary results of a prospective study. Md Med J 48(3):105–110
Weaver DI, Karg DN, Ashikaga T, Harlow SP, O’Connell M (2000) Pathologic analysis of sentinel and non-sentinel lymph nodes in breastcarcinoma: a multicenter study. Cancer 88(5):1099–1107
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ashturkar, A.V., Pathak, G.S., Deshmukh, S.D. et al. Factors Predicting the Axillary Lymph Node Metastasis in Breast Cancer: Is Axillary Node Clearance Indicated in Every Breast Cancer Patient?. Indian J Surg 73, 331–335 (2011). https://doi.org/10.1007/s12262-011-0315-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12262-011-0315-5